- Home
- VNDA vs AMBI Comparison
VNDA vs AMBI Comparison
Compare VNDA & AMBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- AMBI
- Stock Information
- Founded
- VNDA 2002
- AMBI 1995
- Country
- VNDA United States
- AMBI Brazil
- Employees
- VNDA N/A
- AMBI N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- AMBI Environmental Services
- Sector
- VNDA Health Care
- AMBI Industrials
- Exchange
- VNDA Nasdaq
- AMBI Nasdaq
- Market Cap
- VNDA 270.0M
- AMBI 290.4M
- IPO Year
- VNDA 2006
- AMBI N/A
- Fundamental
- Price
- VNDA $4.77
- AMBI $5.65
- Analyst Decision
- VNDA Strong Buy
- AMBI
- Analyst Count
- VNDA 2
- AMBI 0
- Target Price
- VNDA $15.50
- AMBI N/A
- AVG Volume (30 Days)
- VNDA 704.2K
- AMBI 7.5K
- Earning Date
- VNDA 02-05-2025
- AMBI 01-01-0001
- Dividend Yield
- VNDA N/A
- AMBI N/A
- EPS Growth
- VNDA N/A
- AMBI 3161.09
- EPS
- VNDA N/A
- AMBI 0.56
- Revenue
- VNDA $190,858,000.00
- AMBI $504,573,816.00
- Revenue This Year
- VNDA $5.60
- AMBI N/A
- Revenue Next Year
- VNDA $42.85
- AMBI N/A
- P/E Ratio
- VNDA N/A
- AMBI $10.16
- Revenue Growth
- VNDA N/A
- AMBI 25.13
- 52 Week Low
- VNDA $3.46
- AMBI $3.07
- 52 Week High
- VNDA $6.75
- AMBI $8.44
- Technical
- Relative Strength Index (RSI)
- VNDA 42.69
- AMBI 52.34
- Support Level
- VNDA $4.49
- AMBI $5.12
- Resistance Level
- VNDA $4.81
- AMBI $5.93
- Average True Range (ATR)
- VNDA 0.18
- AMBI 0.55
- MACD
- VNDA -0.03
- AMBI 0.07
- Stochastic Oscillator
- VNDA 25.71
- AMBI 80.06
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.
About AMBI Ambipar Emergency Response
Ambipar Emergency Response is a environmental, emergency response and industrial field service provider in Brazil with presence in 16 countries in Latin America, North America, Europe, Africa and Antarctica. The company provides customers with a full suite of environmental services organized around prevention, training and emergency response on all transportation modes. The portfolio includes a broad variety of services such as environmental remediation, industrial field services, industrial cleaning of chemical and non-chemical products and of hazardous and non-hazardous waste, consulting services focused on accident prevention and environmental licensing.